Macro Biologics
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$18.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Macro Biologics is a biotechnology company that develops synthetic biological polymers for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Macro Biologics Comparables
Compare Macro Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prevent-Plus, LLC | 77% | |
| Imbed Biosciences | 76% | |
| Amferia | 74% | |
Macro Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Series A | Sep 4, 2024 | ||||
| Early Funding | Aug 14, 2023 | ||||
| Grant | Jun 6, 2023 | ||||
| Grant | Jun 22, 2020 | ||||
Convertible Debt | Feb 12, 2020 |
Key People
Founding team and executive leadership
Macro Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| CARB-X | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| U.S. Department of War | Grant |
| Oscar & Paul Beiersdorf Venture Capital | Series A |
| Impact Foundation | Early Funding, Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 117% MoM.
- Dec 16, 2025
$5M grant led by CARB-X.
Macro Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Macro Biologics's valuation, stock price, and market status.